Complement in asthma: sensitivity to activation and generation of C3a and C5a via the different complement pathways

Translational Research

Volumn 148, Issue 4, 2006, Pages 157-163

  Wust, Sven K ^a   Blumenthal, Malcolm N ^a   Corazalla, Edward O ^a   Benson, Barbara A ^a   Dalmasso, Agustin P ^a  

^a Department of Laboratory Medicine ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C5A; MANNAN BINDING LECTIN;

ADULT; ALLERGIC ASTHMA; ARTICLE; CLINICAL ARTICLE; COMPLEMENT ACTIVATION; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT BLOOD LEVEL; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT LECTIN PATHWAY; CONTROLLED STUDY; FEMALE; HUMAN; MALE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS;

EID: 33748922465     PISSN: 19315244     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.trsl.2006.05.004     Document Type: Article

References (42)

1. Desai U., Dickey B., Varani J., and Kreutzer D.L. Demonstration of C5 cleaving activity in bronchoalveolar fluids and cells: a mechanism of acute and chronic alveolitis. J Experiment Pathol 1 (1984) 201-216
2. Ember J.A., Jagels M.A., and Hugli T.E. Characterization of complement anaphylatoxins and their biological responses. In: Volanakis J.E., and Frank M.M. (Eds). The human complement system in health and disease (1998), Marcel Dekker, New York 241-284
3. Maruo K., Akaike T., Ono T., Okamoto T., and Maeda H. Generation of anaphylatoxins through proteolytic processing of C3 and C5 by house dust mite protease. J Allergy Clin Immunol 100 (1997) 253-260
4. Nagata S., and Glovsky M.M. Activation of human serum complement with allergens. I. Generation of C3a, C4a, and C5a and induction of human neutrophil aggregation. J Allergy Clin Immunol 80 (1987) 24-32
5. Bjornson A.B., Mellencamp M.A., and Schiff G.M. Complement is activated in the upper respiratory tract during influenza virus infection. Am Rev Respir Dis 143 (1991) 1062-1066
6. Arroyave C.M., Stevenson D.D., Vaughan J.H., and Tan E.M. Plasma complement changes during bronchospasm provoked in asthmatic patients. Clin Allergy 7 (1977) 173-182
7. Smith J.K., Chi D.S., Krish G., Reynolds S., and Cambron G. Effect of exercise on complement activity. Ann Allergy 65 (1990) 304-310
8. Kauffman H.F., van der Heide S., de Monchy J.G., and de Vries K. Plasma histamine concentrations and complement activation during house dust mite-provoked bronchial obstructive reactions. Clin Allergy 13 (1983) 219-228
9. Durham S.R., Lee T.H., Cromwell O., Shaw R.J., Merrett T.G., Merrett J., et al. Immunologic studies in allergen-induced late-phase asthmatic reactions. J Allergy Clin Immunol 74 (1984) 49-60
10. Teran L.M., Campos M.G., Begishvilli B.T., Schroder J.M., Djukanovic R., Shute J.K., et al. Identification of neutrophil chemotactic factors in bronchoalveolar lavage fluid of asthmatic patients. Clin Exp Allergy 27 (1997) 396-405
11. Humbles A.A., Lu B., Nilsson C.A., Lilly C., Israel E., Fujiwara Y., et al. A role for the C3a anaphylatoxin receptor in the effector phase of asthma. Nature 406 (2000) 998-1001
12. Krug N., Tschernig T., Erpenbeck V.J., Hohlfeld J.M., and Kohl J. Complement factors C3a and C5a are increased in bronchoalveolar lavage fluid after segmental allergen provocation in subjects with asthma. Am J Resp Crit Care Med 164 (2001) 1841-1843
13. Lukacs N.W., Glovsky M.M., and Ward P.A. Complement-dependent immune complex-induced bronchial inflammation and hyperreactivity. Amer J Physiol Lung Cell Molec Physiol 280 (2001) L512-L518
14. Peng T., Hao L., Madri J.A., Su X., Elias J.A., Stahl G.L., et al. Role of C5 in the development of airway inflammation, airway hyperresponsiveness, and ongoing airway response. J Clin Invest 115 (2005) 1590-1600
15. Henson P. Complementing asthma. Nature Immunol 1 (2000) 190-192
16. Hawlisch H., Wills-Karp M., Karp C.L., and Kohl J. The anaphylatoxins bridge innate and adaptive immune responses in allergic asthma. Mol Immunol 41 (2004) 123-131
17. Karp C.L., Grupe A., Schadt E., Ewart S.L., Keane-Moore M., Cuomo P.J., et al. Identification of complement factor 5 as a susceptibility locus for experimental allergic asthma. Nature Immunol 1 (2000) 221-226
18. Bautsch W., Hoymann H.G., Zhang Q., Meier-Wiedenbach I., Raschke U., Ames R.S., et al. Guinea pigs with a natural C3a-receptor defect exhibit decreased bronchoconstriction in allergic airway disease: evidence for an involvement of the C3a anaphylatoxin in the pathogenesis of asthma. J Immunol 165 (2000) 5401-5405
19. Drouin S.M., Corry D.B., Kildsgaard J., and Wetsel R.A. The absence of C3 demonstrates a role for complement in Th2 effector functions in a murine model of pulmonary allergy. J Immunol 167 (2001) 4141-4145
20. Drouin S.M., Corry D.B., Hollman T.J., Kildsgaard J., and Wetsel R.A. Absence of the complement anaphylatoxin C3a receptor suppresses Th2 effector functions in a murine model of pulmonary allergy. J Immunol 169 (2002) 5926-5933
21. Walters D.M., Breysse P.N., Schofield B., and Wills-Karp M. Complement factor 3 mediates particulate matter-induced airway hyperresponsiveness. Am J Resp Crit Care Med 27 (2002) 413-418
22. Braun M.C., Lahey E., and Kelsall B.L. Selective suppression of IL-12 production by chemoattractants. J Immunol 164 (2000) 3009-3017
23. Gately M.K., Renzetti L.M., Magram J., Stern A.S., Adorini L., Gubler U., et al. The interleukin-12/interleukin-12-receptor system: role in normal and pathologic immune responses. Ann Rev Immunol 16 (1998) 495-521
24. Marth T., and Kelsall B.L. Regulation of interleukin-12 by complement receptor 3 signaling. J Exp Med 185 (1997) 1987-1995
25. Sutterwala F.S., Noel G.J., Clynes R., and Mosser D.M. Selective suppression of interleukin-12 induction after macrophage receptor ligation. J Exp Med 185 (1997) 1977-1985
26. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 136 (1987) 1285-1298
27. The Collaborative Study on the Genetics of Asthma (CSGA). A genome-wide search for asthma susceptibility loci in ethnically diverse populations. Nat Gen 15 (1997) 389-392
28. National Asthma Education and Prevention Program. Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma. Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Heart, Lung and Blood Institute; 1997. Report No.: NIH publication 97-4051.
29. Roos A., Bouwman L.H., Munoz J., Zuiverloon T., Faber-Krol M.C., Fallaux-van den Houten F.C., et al. Functional characterization of the lectin pathway of complement in human serum. Mol Immunol 39 (2003) 655-668
30. Kroshus T.J., Rollins S.A., Dalmasso A.P., Elliot E.A., Matis L.A., Squinto S.P., et al. Complement inhibition with an anti-C5 monoclonal antibody prevents acute cardiac tissue injury in an ex vivo model of pig-to-human xenotransplantation. Transplantation 60 (1995) 1194-1202
31. Robinson D.S., Hamid Q., Ying S., Tsicopoulos A., Barkans J., Bentley A.M., et al. Predominant TH2-like bronchoalveolar T-lymphocyte population in atopic asthma. N Eng J Med 326 (1992) 298-304
32. Wills-Karp M. Immunologic basis of antigen-induced airway hyperresponsiveness. Annu Rev Immunol 17 (1999) 255-281
33. Eglite S., Pluss K., and Dahinden C.A. Requirements for C5a receptor-mediated IL-4 and IL-13 production and leukotriene C4 generation in human basophils. J Immunol 165 (2000) 2183-2189
34. Abehsira-Amar O., Gibert M., Joliy M., Theze J., and Jankovic D.L. IL-4 plays a dominant role in the differential development of Tho into Th1 and Th2 cells. J Immunol 148 (1992) 3820-3829
35. Kopf M., Le Gros G., Bachmann M., Lamers M.C., Bluethmann H., and Kohler G. Disruption of the murine IL-4 gene blocks Th2 cytokine responses. Nature 362 (1993) 245-248
36. McKenzie G.J., Emson C.L., Bell S.E., Anderson S., Fallon P., Zurawski G., et al. Impaired development of Th2 cells in IL-13-deficient mice. Immunity 9 (1998) 423-432
37. Punnonen J., Aversa G., Cocks B.G., McKenzie A.N., Menon S., Zurawski G., et al. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Nat Acad Sci USA 90 (1993) 3730-3734
38. Carter R.H., and Fearon D.T. CD19: lowering the threshold for antigen receptor stimulation of B lymphocytes. Science 256 (1992) 105-107
39. Arvieux J., Yssel H., and Colomb M.G. Antigen-bound C3b and C4b enhance antigen-presenting cell function in activation of human T-cell clones. Immunology 65 (1988) 229-235
40. Thiel S., Holmskov U., Hviid L., Laursen S.B., and Jensenius J.C. The concentration of the C-type lectin, mannan-binding protein, in human plasma increases during an acute phase response. Clini Exp Immunol 90 (1992) 31-35
41. Koch A., Melbye M., Sorensen P., Homoe P., Madsen H.O., Molbak K., et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA 285 (2001) 1316-1321
42. Garred P., Pressler T., Madsen H.O., Frederiksen B., Svejgaard A., Hoiby N., et al. Association of mannose-binding lectin gene heterogeneity with severity of lung disease and survival in cystic fibrosis. J Clin Invest 104 (1999) 431-437